<DOC>
	<DOCNO>NCT00459641</DOCNO>
	<brief_summary>This randomise , control , open-label study single intralesional administration I-040302 single bone marrow aspirate single steroid injection ( methylprednisolone ) . Subjects undergo screen X-ray magnetic resonance imaging ( MRI ) diagnosis solitary bone cyst .</brief_summary>
	<brief_title>Safety Tolerability I-040302 Children Young Adults With Solitary Bone Cysts</brief_title>
	<detailed_description />
	<mesh_term>Cysts</mesh_term>
	<mesh_term>Bone Cysts</mesh_term>
	<criteria>1 . Subjects 6 16 year age 2 . Diagnostic evidence unicameral bone cyst base one combination follow method : Cyst fluid examination Plain radiograph MRI 3 . Subjects follow type cyst : Intact cyst either grow risk fracture , require surgical intervention Persistence cyst cavity follow cyst fracture receive conservative treatment/s repair fracture Persistence cyst cavity despite repeat intervention 4 . Subjects bone cyst volume &lt; 30 mL 5 . Subjects must appropriately communicative verbalise pain . 6 . Subjects must able understand willing comply protocol procedure . 7 . Subjects provide write informed consent participate study 8 . The legally authorised representative child must give write informed consent child agree participate study . 1 . A history of/or presence active cancer 2 . Family history retinoblastoma 3 . Indication aneurysmal bone cyst MRI , cyst aspiration histology 4 . Possible presence osteosarcoma uncertain histology 5 . Systemic localise infection time surgery 6 . Evidence immunesuppression 7 . Evidence hypercalcemia 8 . Cyst volume &gt; 30 mL 9 . Fracture present cortical bone surround cyst 10 . Evidence rapid venous drainage cyst determine rapid disappearance Xray contrast medium surgical process . 11 . Suspected known evidence allergic reaction towards component I040302 12 . Known clinically significant organ systemic disease , opinion investigator , significance disease compromise subject 's participation study 13 . Pregnant lactating female 14 . Participation another clinical trial within 3 month prior trial start</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Osteogenic Gel</keyword>
	<keyword>Solitary Bone Cysts</keyword>
</DOC>